China NMPA Product Recall - Implantable deep brain stimulation extension lead, implantable spinal cord stimulation electrode, implantable spinal cord stimulation extension lead kit

On September 15, 2023, the National Medical Products Administration (NMPA) announced a voluntary Level III recall initiated by Medtronic Inc., specifically through its Chinese entity, Medtronic (Shanghai) Management Co., Ltd. The recall impacts several critical implantable medical devices, including deep brain stimulation extension leads, and various implantable spinal cord stimulation electrodes and extension lead kits. The primary reason for this action is a regulatory compliance issue: specific electronic instruction manuals (eIFUs) for these products have not yet been made available online, as required. This oversight means essential user information is not readily accessible, posing a potential concern for proper device usage. Operating under the NMPA's regulatory framework, Medtronic is undertaking this voluntary recall to address the documentation discrepancy. The required action involves removing the affected product batches from distribution. Comprehensive details regarding the specific models, specifications, and batch numbers of the recalled devices are documented in the 'Medical Device Recall Event Report Form' submitted by Medtronic, ensuring transparency and appropriate action for this significant product correction.